InvestorsHub Logo
Followers 91
Posts 11249
Boards Moderated 0
Alias Born 06/06/2014

Re: runninggirl2016 post# 157495

Thursday, 08/25/2016 11:54:06 AM

Thursday, August 25, 2016 11:54:06 AM

Post# of 402535
Yes this is a job for an MDM2 inhibitor since the problem is not p53 mutation. Which is why this study uses RITA, an MDM2 inhibitor. Kevetrin may be effective here if its theorized MDM2-phosphorylation properties hold up, which would be exciting.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent IPIX News